Literature DB >> 17562055

[Bone metabolism: molecular mechanisms].

E Neumann1, G Schett.   

Abstract

In order to accommodate individual load, the skeletal system is in a continual state of change. Bone metabolism guarantees optimal bone structure. The osteoblasts are responsible for the synthesis and the osteoclasts for resorption of the bone. A finely adjusted interplay between molecular mechanisms leads, via cytokines, hormones and growth factors, to an homeostasis in bone metabolism. Disturbances of this process lead via increased bone resorption to osteoporosis, and via increased synthesis to osteopetrosis. This contribution describes the known molecular mechanisms in this remodelling process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562055     DOI: 10.1007/s00393-007-0182-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  37 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  High-sensitivity C-reactive protein and fracture risk in elderly women.

Authors:  Julie A Pasco; Mark A Kotowicz; Margaret J Henry; Geoffrey C Nicholson; Heather J Spilsbury; Jeffrey D Box; Hans G Schneider
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

Review 3.  Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.

Authors:  Paul J Kostenuik
Journal:  Curr Opin Pharmacol       Date:  2005-09-26       Impact factor: 5.547

4.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 5.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

Review 6.  Regulation of bone mass by Wnt signaling.

Authors:  Venkatesh Krishnan; Henry U Bryant; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

7.  High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study.

Authors:  Georg Schett; Stefan Kiechl; Siegfried Weger; Angelo Pederiva; Agnes Mayr; Manuele Petrangeli; Friedrich Oberhollenzer; Rolando Lorenzini; Kurt Redlich; Roland Axmann; Jochen Zwerina; Johann Willeit
Journal:  Arch Intern Med       Date:  2006 Dec 11-25

8.  The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts.

Authors:  S Bord; D C Ireland; S R Beavan; J E Compston
Journal:  Bone       Date:  2003-02       Impact factor: 4.398

9.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 10.  The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.

Authors:  E M Gravallese; D L Galson; S R Goldring; P E Auron
Journal:  Arthritis Res       Date:  2000-11-02
View more
  5 in total

Review 1.  The molecular mechanism behind bone remodelling: a review.

Authors:  Peter Proff; Piero Römer
Journal:  Clin Oral Investig       Date:  2009-03-25       Impact factor: 3.573

Review 2.  Adipokines in bone disease.

Authors:  Elena Neumann; Susann Junker; Georg Schett; Klaus Frommer; Ulf Müller-Ladner
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

Review 3.  [Inflammation and bone metabolism].

Authors:  E Neumann; U Müller-Ladner; K W Frommer
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

4.  [Influence of adjuvant pain medication on quality of life in the treatment of postmenopausal osteoporosis].

Authors:  D Krocker; H Ullrich; F Buttgereit; C Perka
Journal:  Orthopade       Date:  2008-05       Impact factor: 1.087

Review 5.  [Inflammation and bone : Osteoimmunological aspects].

Authors:  K W Frommer; E Neumann; U Lange
Journal:  Z Rheumatol       Date:  2016-06       Impact factor: 1.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.